Document Type : Original article
Authors
1 Department of Ophthalmology, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran
2 Metabolic Diseases Research Center, Research Institute for Prevention of Non‑Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
Abstract
Keywords
Abstract
Background: Retinopathy of Prematurity (ROP) is a pathologic condition in the retina characterized by abnormal vasoproliferation. We aim to investigate the correlation of different birth- and hospitalization-related factors in the progression of ROP.
Methods: This historical cohort study performed in the ophthalmology center of Ayatollah Rouhani Hospital in Babol (Babol University of Medical Sciences, Babol, Iran), included 828 infants (gestational age <35 weeks and birth weight <2500 g). Also, data were collected from the history of hospitalized premature infants.
Results: The lower gestational weight of infants has been observed in ROP infants (1418.05±547.09 g) compared to non-ROP infants (1917.31±486.01 g) (p<0.001). In addition, the average gestational age of ROP infants (30.28±2.34 weeks) was younger than non-ROP infants (33.26±1.00 weeks) (p=0.042). Increase in the duration of hospitalization increased 6% the chance of ROP in infants (OR=1.06; 95%CI: [1.05,1.08]) (p<0.001). Furthermore, increase in the count of blood replacement decreased 29% the chance of complete remission of ROP (OR=0.71; 95%CI: [0.51,0.95]) (p=0.029). The blood group does not have an impact on ROP development or remission.
Conclusion: More birth weight of premature infants is associated with less chance of ROP incidence. Moreover, the lower gestational age is related to more chances of ROP.
Keywords: Hospitalization, Infant, Premature infant, Retinopathy of prematurity
Introduction
Retinopathy of Prematurity (ROP) is an infantile retinal disease corresponding to lifetime visual impairment and blindness (1,2). ROP affects over 33% of premature infants (3). ROP is characterized by abnormal intravitreal neovascularization in the premature retina (4-6). ROP is created by abnormal intravitreal neovascularization in the developing retina. ROP is a multifactorial disease resulting in genetic disorders and environmental conditions. A profound investigation of ROP infants establishes the role of different factors in the progression of ROP. The identification of risk factors helps the prevention of the progression of ROP (7).
Some general risk factors affect fetal diseases, i.e., placental and fetal problems (8,9). Also, studies show that some irrelevant conditions may affect fetal diseases, i.e., sex, blood group, days of hospitalization of infants, count of blood replacement (in required cases), type of delivery, CPR requirement, surfactant requirement, and phototherapy requirement (10-12). In this blinded study, we investigated the impact of the general parameters as potential factors of ROP such as gestational weight, gestational age, duration of hospitalization, count of blood replacement, sex, blood group, type of delivery, Cardio-Pulmonary Resuscitation (CPR) requirement, surfactant requirement, and phototherapy.
Materials and Methods
This historical cohort study was performed in the Ophthalmology and NICU departments of Ayatollah Rouhani Hospital in Babol (Babol University of Medical Sciences, Babol, Iran) and included 828 infants (303 ROP infants as cases and 525 non-ROP infants as controls). Institutional ethics committee approval was obtained from the Local Ethics Committee (IR.MUBABOL.REC.1399.373). Initial examinations were performed one hour after the administration of 2.5% phenylephrine and 0.5% tropicamide and funduscopic examinations implemented by using a binocular indirect ophthalmoscope, 28D lens, scleral depressor, and pediatric speculum in the NICU department. In case there was an ROP, the regular follow-up examinations were continued until complete remission was achieved (defined as complete retinal vascularization and regression of ROP). In addition, treatment protocol, including anti-vascular endothelial growth factor injection, was conducted according to the International Classification of Retinopathy of Prematurity (ICROP) criteria for stage III ROP patients. The infants were separated into two groups: the infants with no signs of ROP as the control group and infants with different stages of ROP as the case group.There was only stage 1, 2, and 3 of ROP in patients and none of the infants had stages 4 and 5.
The inclusion criteria included the age of <35 weeks, birth weight <2500 g, and conscious parental consent. The exclusion criteria were the age of over 35 weeks, birth weight of more than 2500 g, and secondary ophthalmic conditions.
Statistical analysis was performed using the SPSS 21.0 software. Quantitative variables were reported with mean±SD. Chi-square and independent T-test were utilized to evaluate univariate comparisons of risk factors between the groups. The level of significance was taken to be p<0.05 for all statistical tests.
Results
The impact of effectors on the incidence of ROP
The lower gestational weight of infants has been observed in ROP infants (1418.05±547.09 g) compared to non-ROP infants (1917.31±486.01 g) (p<0.001). Also, the average gestational age of ROP infants (30.28±2.34 weeks) was younger than non-ROP infants (33.26±1.00 weeks) (p=0.042). Mean±SD of days of hospitalization was higher in ROP infants (31.69±21.11 days) compared to non-ROP infants (14.67±13.36 days) (p<0.001) (Table 1). There was no significant correlation between ROP incidence and sex, blood group, type of delivery, CPR requirement, surfactant requirement, and phototherapy requirement in infants.
Table 1. Correlation of ROP (diagnosed in the first examination) and clinical/paraclinical data
Name |
Level |
Total |
Non-ROP infant (n=525) |
ROP infant (n=303) |
p-value |
Gestational weight (g) |
1788.35±567.54 |
1917.31±486.01 |
1418.05±547.09 |
<0.001 |
|
Gestational age (weeks) |
32.17±6.95 |
33.26±1.00 |
30.28±2.34 |
0.042 |
|
Days of hospitalization (day) |
19.29±17.96 |
14.67±13.36 |
31.69±21.11 |
<0.001 |
|
Count of blood replacement |
1.10±5.26 |
1.32±7.53 |
1.27±1.44 |
0.925 |
|
Sex |
Female |
377 (45.81%) |
242 (46.1%) |
135 (45.3%) |
0.808 |
Male |
446 (54.19%) |
283 (53.9%) |
163 (54.7%) |
||
Blood group |
A+ |
115 (26.62%) |
76 (26.95%) |
39 (26%) |
0.242 |
A- |
7 (1.62%) |
7 (2.48%) |
0 (0%) |
||
B+ |
103 (23.84%) |
70 (24.82%) |
33 (22%) |
||
B- |
10 (2.31%) |
7 (2.48%) |
3 (2%) |
||
O+ |
150 (34.72%) |
90 (31.91%) |
60 (40%) |
||
O- |
14 (3.24%) |
12 (4.26%) |
2 (1.33%) |
||
AB+ |
29 (6.71%) |
18 (6.38%) |
11 (7.33%) |
||
AB- |
4 (0.93%) |
2 (0.71%) |
2 (1.33%) |
||
Type of delivery |
Normal vaginal delivery |
74 (17.49%) |
43 (17.06%) |
31 (18.13%) |
0.809 |
Cesarean delivery |
349 (82.51%) |
209 (82.94%) |
140 (81.87%) |
||
CPR requirement |
No |
69 (32.86%) |
44 (36.97%) |
25 (27.47%) |
0.170 |
Yes |
141 (67.14%) |
75 (63.03%) |
66 (72.53%) |
||
Surfactant requirement |
No |
8 (3.59%) |
5 (4.5%) |
3 (2.68%) |
0.238 |
Yes |
213 (95.52%) |
104 (93.69%) |
109 (97.32%) |
||
Missed data |
2 (0.9%) |
2 (1.8%) |
0 (0%) |
||
Phototherapy |
No |
7 (2.9%) |
4 (2.4%) |
3 (4.05%) |
0.849 |
Yes |
224 (92.95%) |
156 (93.41%) |
68 (91.89%) |
||
Missed data |
10 (4.15%) |
7 (4.19%) |
3 (4.05%) |
The investigation of odds ratio of effectors on ROP shows that the increase in gestational age decreased 40% the chance of ROP in infants (OR=0.6; 95%CI: [0.56,0.65]) (<0.001). In addition, increase in the duration of hospitalization increased 6% the chance of ROP in infants (OR=1.06; 95%CI: [1.05,1.08]) (<0.001). Intrauterine growth restriction (IUGR) decreased 67% the chance of ROP in infants (OR=0.33; 95%CI: [0.17,0.64]) (<0.001) (Table 2).
Table 2. Odds ratio of effectors in ROP incidence
Factors |
OR (95% CI) |
p-value |
|
Gestational age |
0.6 (0.56,0.65) |
<0.001 |
|
Blood group |
A- |
0.1 (0.01,1.79) |
0.117 |
B+ |
0.93 (0.54,1.63) |
0.805 |
|
B- |
0.86 (0.24,3.28) |
0.827 |
|
O+ |
1.31 (0.8,2.14) |
0.277 |
|
O- |
0.38 (0.09,1.5) |
0.167 |
|
AB+ |
1.2 (0.54,2.7) |
0.665 |
|
AB- |
1.69 (0.3,10.24) |
0.552 |
|
Count of blood replacement |
1 (0.95,1.04) |
0.939 |
|
CPR requirement |
1.55 (0.86,2.82) |
0.147 |
|
Days of hospitalization |
1.06 (1.05,1.08) |
<0.001 |
|
Fetal problem |
1.39 (0.94,2.08) |
0.102 |
|
Placental problem* |
Decollement |
1.57 (0.57,4.31) |
0.38 |
Placenta previa |
8.4 (0.39,165.34) |
0.165 |
|
IUGR |
0.33 (0.17,0.64) |
<0.001 |
|
Surfactant requirement* |
No |
1.83 (0.49,6.82) |
0.377 |
Yes |
0.25 (0.01,6.36) |
0.395 |
|
Type of delivery |
0.93 (0.56,1.56) |
0.777 |
|
Phototherapy |
No |
0.58 (0.12,3.02) |
0.485 |
Yes |
0.57 (0.07,4.43) |
0.587 |
|
Sex (male) |
1.03 (0.78,1.37) |
0.826 |
|
Gestational weight |
1 (1,1) |
<0.001 |
* Calculated by Bayesian Logistic regression due to data sparsity.
The impact of effectors on complete remission of ROP
The results of the impact of effectors on complete remission of ROP show that higher gestational age increases the chance of complete remission of ROP by about 21% in ROP infants (OR=1.21; 95%CI: [1.08, 1.36]) (p<0.001). Moreover, increase in the count of blood replacement decreased 29% the chance of complete remission of ROP (OR =0.71; 95%CI: [0.51, 0.95]) (p=0.029) and more time on hospitalization reduced 2% (OR=0.98; 95%CI: [0.96, 0.99]) (p=0.004) the chance of complete remission of ROP in ROP infants. Other factors, e.g., blood groups, did not affect the chance of complete remission of ROP (Table 3).
Table 3. Effect of different factors to increase or decrease complete remission chance of ROP
Factors |
OR (95% CI) |
p-value |
|
Gestational age |
1.21 (1.08,1.36) |
0.001 |
|
Blood group* |
A- |
1.01 (0.01,132.03) |
1 |
B+ |
1.8 (0.65,5.05) |
0.271 |
|
B- |
0.37 (0.05,2.83) |
0.349 |
|
O+ |
0.66 (0.29,1.49) |
0.329 |
|
O- |
3.69 (0.18,75.68) |
0.403 |
|
AB+ |
0.57 (0.15,2.2) |
0.402 |
|
AB- |
3.74 (0.18,81.32) |
0.403 |
|
Count of blood replacement |
0.71 (0.51,0.95) |
0.029 |
|
CPR requirement |
0.75 (0.26,2.03) |
0.579 |
|
Days of hospitalization |
0.98 (0.96,0.99) |
0.004 |
|
Fetal problem |
1.31 (0.74,2.52) |
0.378 |
|
Placental problem |
Decollement |
1.82 (0.38,12.84) |
0.481 |
Placenta Previa |
0.73 (0.03,18.5) |
0.822 |
|
IUGR |
0.73 (0.2,2.67) |
0.62 |
|
Surfactant requirement* |
No |
0.14 (0.01,2.8) |
0.194 |
Yes |
1.03 (0.01,131.34) |
1 |
|
Type of delivery |
0.42 (0.17,0.97) |
0.052 |
|
Phototherapy |
No |
0.59 (0.03,6.42) |
0.669 |
Yes |
1 (0.02,40.4) |
1 |
|
Sex |
0.65 (0.39,1.05) |
0.082 |
|
Gestational weight |
1 (1,1) |
<0.001 |
* Calculated by Bayesian Logistic regression due to data sparsity.
The impact of effectors on remission of ROP in terms of the stage and zone
The results of Bayesian Logistic regression show that none of the factors affect the stage of ROP (reduction of the stage of ROP) and deterioration of the zone of ROP (reduction of the zone of ROP) between two examinations (Tables 4 and 5).
Table 4. Effects of the different factors on decreasing the stage of ROP (revealing the ROP in terms of the stage)
Factors |
OR (95% CI) |
p-value |
|
Gestational age |
1.04 (0.79,1.39) |
0.804 |
|
Blood group* |
A- |
0.97 (0.01,132.73) |
1 |
B+ |
2.59 (0.1,60.74) |
0.56 |
|
B- |
1.55 (0.04,62.28) |
0.809 |
|
O+ |
0.27 (0.04,1.77) |
0.177 |
|
O- |
1.01 (0.01,138.07) |
1 |
|
AB+ |
2.18 (0.07,62.85) |
0.639 |
|
AB- |
1 (0.01,148.41) |
1 |
|
Count of blood replacement |
0.82 (0.51,1.34) |
0.396 |
|
CPR requirement* |
0.35 (0.01,8.44) |
0.520 |
|
Days of hospitalization |
0.98 (0.94,1.02) |
0.233 |
|
Fetal problem |
1.11 (0.29,18.55) |
0.906 |
|
Placental problem* |
Decollement |
1.72 (0.05,60.88) |
0.764 |
Placenta previa |
1.39 (0.03,65.32) |
0.862 |
|
IUGR |
2.44 (0.11,58.13) |
0.564 |
|
Type of delivery |
3.47 (0.43,20.62) |
0.187 |
|
Phototherapy* |
No |
0.57 (0.01,20.94) |
0.772 |
Yes |
1.25 (0.02,83.46) |
0.904 |
|
Sex (male) |
0.76 (0.15,3.04) |
0.704 |
|
Gestational weight |
1 (1,1) |
0.979 |
* Calculated by Bayesian Logistic regression due to data sparsity.
Table 5. Effect of the different factors on decreasing the zone of ROP (deterioration of ROP in terms of the zone)
Factors |
OR (95% CI) |
p-value |
|
Gestational age |
1.12 (0.91,1.4) |
0.3 |
|
Blood group |
B+ |
0.12 (0.01,1.25) |
0.103 |
B- |
0.09 (0,3.43) |
0.173 |
|
O+ |
0.19 (0.01,1.27) |
0.145 |
|
AB+ |
0.36 (0.01,10.68) |
0.508 |
|
Count of blood replacement |
0.95 (0.63,1.48) |
0.815 |
|
CPR requirement |
1.28 (0.15,8.34) |
0.801 |
|
Days of hospitalization |
0.98 (0.96,1.01) |
0.237 |
|
Fetal problem |
0.42 (0.13,1.22) |
0.112 |
|
Placental Problem |
Decollement |
2.23 (0.09,57.33) |
0.622 |
Placenta previa |
1.73 (0.05,59.34) |
0.767 |
|
IUGR |
0.38 (0.07,2.15) |
0.279 |
|
Type of delivery |
1.36 (0.18,6.92) |
0.725 |
|
Phototherapy |
No |
3.62 (0.25,52.37) |
0.354 |
Yes |
3.52 (0.1,121.85) |
0.484 |
|
Sex |
0.81 (0.28,2.17) |
0.679 |
|
Gestational weight |
1 (1,1) |
0.28 |
* Calculated by Bayesian Logistic regression due to data sparsity.
Discussion
ROP is a vasoproliferative retinal disease in premature infants. ROP is the major cause of lifetime visual impairment and blindness at an early age. ROP is a multifactorial disease, and a large number of studies have been conducted to analyze the relationship between pathogenesis of ROP and risk factors such as low birth weight, short gestational age, hypoxia, and other factors. Also, several factors involving birth conditions and infantile problems are associated with ROP progression. In this study, the role of different factors were investigated in terms of birth conditions and infantile problems of ROP infants.
The higher gestational weight of infants has been observed in non-ROP infants (1917.31±486.01 g) compared to ROP infants (1418.05±547.09 g) (p<0.001). This result reveals that ROP is more progressed in more prematurity conditions. In other words, less weight of infants is more common in ROP infants. This condition is probably due to less completed development of the retina and less vascularization to oxygen delivery. In a study conducted by by Eckert et al, it has been shown that less bodyweight is a predictor of any stage and severe ROP (13). Also, in a study by Aydemir et al, poor weight gain for birth weight was considered as a predictor of ROP (14). Due to these results, a completed nutrition therapy might be suitable for mothers to more weighting of infants. Regarding this hypothesis, a meta-analysis study by Vayalthrikkovil et al, parenteral administration of fish-oil lipid emulsions significantly reduced the incidence of severe ROP and laser therapy requirement (15). Furthermore, a study by Lenhartova et al showed that providing enough nutrients for infants in the pregnancy period and early enteral feeding breast milk of their own mother leads to a significant reduction in the severity of ROP (16). Upadhyay et al stated that infants receiving early optimal nutrition therapy had less incidence of ROP (17).
Mean±SD of days of hospitalization was higher in ROP infants (31.69±21.11 days) compared to non-ROP infants (14.67±13.36 days) (p<0.001). It seems that days of hospitalization are an independent but significant correlated factor to the progression of ROP that refers to a worse condition of premature infants, which is related to more prevalence of ROP.
Also, the average gestational age of ROP infants (30.28±2.34 weeks) was younger compared to non-ROP infants (33.26±1.00 weeks) (p=0.042). Contrary to the result, Wu et al showed that less gestational age is associated with a healthy state in terms of ROP (18). It seems that gestational age requires more studies to the identification of its role in ROP progression. In the investigation of infant problems, the results show that Intrauterine Growth Restriction (IUGR) decreases 67% the chance of ROP in infants, while Nong et al failed to find any association between IUGR and ROP (19). There is no other study on the impact of IUGR in ROP.
The results of the current study show that the increase in the count of blood replacement decreased 29% the chance of complete remission of ROP (p=0.029). This result established that the requirement for blood replacement, which is an indicator of the blood-related disease, is associated with ROP progression. In other words, the less requirement of blood replacement promises a better prognosis for ROP. Moreover, there is no difference between the different blood groups and the chance of ROP incidence.
Conclusion
In this study, it was found that the lower gestational weight, the lower gestational age, and the increased duration of hospitalization are associated with an increased chance of ROP. Also, an increase in the count of blood replacement decreases the chance of complete remission of ROP. To continue, we recommend studying more ROP infants and investigating the effect of underlying diseases on ROP in premature Iranian infants to introduce a novel prognostic marker for ROP. Indeed, the results of our study and correlated studies help more suitable medical care for ROP infants to prevent their disease-related disabilities.
Acknowledgements
We would like to express our special thanks to the NICU department of Ayatollah Rouhani Hospital, Babol, Iran.
Conflict of Interest
There is no conflict of interest in this manuscript.